5nance5nance
5nance5nance
HomeScreens
LOGINGET FREE ACCOUNT

Dr. Lal Pathlabs Ltd.

•
lalpathlabs.comBSE: 539524NSE: LALPATHLAB
Market Cap₹ 32,049 Cr.
Current Price
High / Low₹ 1,989 / 1,273
Stock P/E58.8
Book Value₹ 153
Price to Book9.15
Dividend Yield1.07 %
ROCE29.6 %
ROE22.7 %
Face Value₹ 10

Add ratio to table

ABOUT

AI Sector View

AI GENERATED

Healthcare

Buy

This stance relies on proxies and positioning because no direct pharma-export or healthcare operating series exists in the dataset. The depreciated currency at 95.23 (Sep/26) can support export earnings, inflation at 4.45% (Jul/26) is manageable for a defensive sector, and consumer spending remains large at INR 44743 billion (Jun/26). Strong FPI inflow of INR 10620 crore over 3 months to 2026-08-31 from INR -11381 crore in the prior 3 months adds a real sector-specific tailwind, but confidence stays capped because the fundamental drivers are indirect proxies.

Confidence
50%
View full sector analysis →

PROS

  • Company is almost debt free
  • Company has a healthy return on capital (ROCE) of 29.5%
  • Company has a good return on equity (ROE) track record: 3 Years ROE 23.1%
  • Latest quarter profit grew 28.3% YoY, showing strong momentum
  • Strong cash generation - operating cash flow backs reported profits (CFO/PAT 1.22x)
  • Company has been maintaining a healthy dividend payout of 67.6%

CONS

  • Valuation is stretched - P/E of 58.8 is well above its own 5-year median (27.2)
  • Stock is trading at 9.1x its book value
  • Expensive relative to growth - PEG of 2.9

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

HealthcareHealthcareHospital & Healthcare Services
Part ofNIFTY TOTAL MKTNIFTY SML250 Q50NIFTY SMLCAP 50NIFTY 500NIFTY SMLCAP 250
S.No.Name
1.APOLLOHOSP8850.0060.90127249.420.23610.4038.417043.5020.5621.7315.70
2.MAXHEALTH1037.2069.29100951.740.19322.964.872366.1716.7014.9725.29
3.MANIPALHOS716.15105.5794200.740.002434.30—30906.30—13.9323.83
4.FORTIS887.3063.9366987.440.11272.802.262545.0317.4614.0721.28
5.ASTERDM762.95208.6966504.250.3929.28-68.701310.6821.6011.2619.53
6.MEDANTA1447.5569.9838920.530.03157.25-1.091304.0526.5019.3821.99
7.NH1867.3546.7638161.310.24207.275.372683.6378.0516.2017.43
8.KIMS768.85158.0632292.200.0037.40-56.001179.5035.3311.5119.03
9.LALPATHLAB1909.4059.1432049.051.071705.001172.397977.001090.9529.5631.03
10.AGARWALEYE507.00108.3316073.230.0055.0244.56614.0225.9716.1427.75
11.VIJAYA1502.3082.5315473.350.1353.1037.61230.9822.8330.2842.66
12.RAINBOW1443.4051.3714660.130.2462.5416.23469.9933.1728.2528.65
Detailed Comparison with:

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
4805324765215746315695776417006326757,644
3443693463834134374184184574844584945,720
Operating Profit1361631301381611941511591832151741821,924
OPM %28.29%30.66%27.33%26.42%28.08%30.75%26.53%27.56%28.62%30.75%27.48%26.88%25.17%
15141516312431252623-437299
Interest77666655457661
Depreciation181919353333343533384043400
Profit before Tax1251511201131541791441451721951231702,223
Tax %25.18%25.12%26.11%28.62%25.50%28.04%26.60%-2.42%25.00%25.21%25.18%16.95%25.37%
Net Profit941138881114129105148129146921411,659
11.2813.6010.789.7013.7615.476.338.9015.5117.465.528.459.94

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
8821,0241,1651,2741,4911,8791,7692,1252,3522,6489,651
6527688829461,0831,3661,3081,5441,6861,8947,157
Operating Profit2302562833284075124615816657542,494
OPM %26.09%25.01%24.28%25.74%27.33%27.28%26.04%27.32%28.30%28.47%25.85%
283246585153476611283355
Interest1111515293429212278
Depreciation26313668707682136134154521
Profit before Tax2312562923033744613914836216602,711
Tax %34.06%34.21%33.15%26.28%25.11%25.11%25.20%28.14%19.96%23.03%24.82%
Net Profit1521681952232803452923474975082,038
EPS18.6920.5223.6927.0433.8541.6335.1741.5459.4930.33—
Dividend Payout %16.34%22.29%25.59%44.81%59.51%28.97%34.22%57.78%40.34%67.59%—

COMPOUNDED SALES GROWTH

10 Years:
13%
5 Years:
12%
3 Years:
14%

COMPOUNDED PROFIT GROWTH

10 Years:
15%
5 Years:
13%
3 Years:
20%

STOCK PRICE CAGR

10 Years:
13%
5 Years:
-2%
3 Years:
20%
1 Year:
16%

RETURN ON EQUITY

10 Years:
24%
5 Years:
23%
3 Years:
23%
Last Year:
23%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Corporate actions

2025

Dec 19

1:1

Interim Dividend & Bonus issue & Quarterly Results

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital838383838383838384168
4956758199001,0941,3311,5481,6661,9942,239
781901044663519898142
Trade Payables516277113136123140180163176
275064109130176164277198243
Total Liabilities6638791,0451,2961,5462,1812,2882,3052,5362,968
1211731732973003713611,0711,0181,110
Capital Work in Progress1593106143435
1341742142531711,0621,213213416513
17272855394023333241
000000087105134
Cash & Bank235307478549889543534752768844
141190150132142151152145194320
Total Assets6638791,0451,2961,5462,1812,2882,3052,5362,968

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
313281311361470543527505540606
Cash from Investing-134-166-93-19-195-449-2881-293-382
Cash from Financing-3213-54-187-136141-270-411-325-256
136616542118-13195-78-32

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026

Shareholding Pattern

Numbers in percentages

Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
54.6053.9253.9153.9153.7953.2153.2153.2153.19
25.4326.8226.8223.9021.6921.8620.2917.1817.35
12.4212.6012.8815.7917.4918.0819.0621.2321.45
0.000.000.000.000.000.000.010.010.01
7.266.376.116.106.746.587.438.357.99

Documents

Corporate disclosures, annual reports, credit ratings, and concall transcripts

2026-09-04
Copy of Newspaper Publication

2026-09-04 - Dr. Lal Path Labs Ltd. has informed the Exchange about Copy of Newspaper Publication

2026-08-27
General Updates

2026-08-27 - Dr. Lal Path Labs Ltd. has informed the Exchange about General Updates

2026-08-19
General Updates

2026-08-19 - Incorporation of a Step-Down Subsidiary Company

2026-08-06
ESOP/ESOS/ESPS

2026-08-06 - Dr. Lal Path Labs Ltd. has informed the Exchange regarding Allotment of 211050 Shares.

2026-07-30
Analysts/Institutional Investor Meet/Con. Call Updates

2026-07-30 - Dr. Lal Path Labs Ltd. has informed the Exchange about Transcript

2026-07-26
Change in Director(s)

2026-07-26 - Dr. Lal Path Labs Ltd. has informed the Exchange regarding Change in Director(s) of the company.

2026-07-25
Shareholders meeting

2026-07-25 - Dr. Lal Path Labs Ltd. has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on July 25, 2026. Further, the company has informed the Exchange regarding voting results.

2026-07-25
Shareholders meeting

2026-07-25 - Dr. Lal Path Labs Ltd. has informed the Exchange regarding Proceedings of Annual General Meeting held on July 25, 2026

2026-07-25
Copy of Newspaper Publication

2026-07-25 - Dr. Lal Path Labs Ltd. has informed the Exchange about Copy of Newspaper Publication

News

Recent coverage and analyst commentary for LALPATHLAB

Loading news…

🤖

AI Stock Analyst

Dr. Lal Pathlabs Ltd.

🔒

Sign in to Chat with AI

Log in with your 5nance account to ask institutional questions about performance, financials, and outlook.

✨ Sign In to Chat

Free 5nance Account

5nance5nance

Stock analysis and screening tool

5nanceAI © 2020-2026

Made with ❤️ in India.

Data provided by Accord Fintech

Terms & Privacy.

Product

PremiumWhat's new?Learn

Team

About usSupport

Theme

5nance5nance

Product

PremiumWhat's new?Learn

Team

About usSupport

Theme

5nanceAI © 2020-2026

Data provided by Accord Fintech

Made with ❤️ in India.

HomeScreens
Login